RECRUITING

Five Point Initiative: A Bundled Implementation Strategy to Address the HIV Epidemic in Black Communities

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to assess the effectiveness of the FPI bundled implementation strategy in increasing HIV testing, Pre-exposure prophylaxis (PrEP) linkage (e.g., prescription) and knowledge, and condom use/access.

Official Title

Five Point Initiative: A Cluster Randomized Trial of a Bundled Implementation Strategy to Address the HIV Epidemic in Black Communities

Quick Facts

Study Start:2024-02-02
Study Completion:2029-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06062342

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Any individual present during the community events at the "five points" (barbershop, hair/beauty salon store or salon, corner store/grocery/neighborhood restaurant, laundromats, car service provider \[e.g. gas station, mechanic, car wash\]) in predominantly Black communities in Miami where HIV prevalence is high.
  2. * Pre- and Post-assessment: Individuals are only eligible to complete the survey one time during the Pre-Intervention and during the Post-Intervention phases.
  3. * Intervention: Individuals are only eligible to participate in the Intervention phase of this study once every 6 months.
  1. * Individuals who are unable to completely and fully understand the informed (verbal) consent process and the study procedures.
  2. * Individuals who have previously completed the survey during the Pre-Intervention and Post-Intervention phases.
  3. * Individuals who have participated in the Intervention phase of this study within less than 6 months.

Contacts and Locations

Study Contact

Sannisha Dale, PhD
CONTACT
(305) 243-6714
sdale@med.miami.edu
SHINE Research Program
CONTACT
shineresearch@miami.edu

Principal Investigator

Sannisha Dale, PhD
PRINCIPAL_INVESTIGATOR
University of Miami

Study Locations (Sites)

University of Miami
Miami, Florida, 33136
United States

Collaborators and Investigators

Sponsor: University of Miami

  • Sannisha Dale, PhD, PRINCIPAL_INVESTIGATOR, University of Miami

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-02-02
Study Completion Date2029-06-30

Study Record Updates

Study Start Date2024-02-02
Study Completion Date2029-06-30

Terms related to this study

Keywords Provided by Researchers

  • HIV prevention
  • HIV testing
  • PrEP
  • Implementation Science

Additional Relevant MeSH Terms

  • Hiv